{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T23:17:04Z","timestamp":1776208624849,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.revmed.2007.06.002","type":"journal-article","created":{"date-parts":[[2007,6,27]],"date-time":"2007-06-27T07:12:52Z","timestamp":1182928372000},"page":"825-831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Histoire naturelle de\u00a0la\u00a0lipodystrophie cervicofaciale cortico-induite : suivi prospectif d'une cohorte de\u00a037\u00a0patients"],"prefix":"10.1016","volume":"28","author":[{"given":"L.","family":"Fardet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Flahault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kettaneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.P.","family":"Tiev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Tol\u00e9dano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Cabane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2007.06.002_bib1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/bmj.313.7053.344","article-title":"Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study","volume":"313","author":"Walsh","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.revmed.2007.06.002_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/qjmed\/93.2.105","article-title":"Use of oral corticosteroids in the United Kingdom","volume":"93","author":"Van Staa","year":"2000","journal-title":"QJM"},{"key":"10.1016\/j.revmed.2007.06.002_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1378\/chest.48.3.287","article-title":"Long term (five or more years) administration of corticosteroids in pulmonary diseases","volume":"48","author":"Shubin","year":"1965","journal-title":"Dis. Chest"},{"key":"10.1016\/j.revmed.2007.06.002_bib4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7326\/0003-4819-134-2-200101160-00010","article-title":"Combined treatment of giant-cell arteritis with methotrexate and prednisone. A randomized, double-blind, placebo-controlled trial","volume":"134","author":"Jover","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.revmed.2007.06.002_bib5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1067\/mai.2000.109830","article-title":"Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma","volume":"106","author":"Covar","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.revmed.2007.06.002_bib6","unstructured":"Fardet L, Cabane J, Lebb\u00e9 C, Morel P, Flahault A. Incidence and risk factors for corticosteroid-induced lipodystrophy: a prospective study. Sous presse, J. Am. Acad. Dermatol."},{"key":"10.1016\/j.revmed.2007.06.002_bib7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2796.1994.tb00855.x","article-title":"Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy","volume":"236","author":"Conn","year":"1994","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.revmed.2007.06.002_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00004836-200110000-00006","article-title":"Side effects of corticosteroid therapy","volume":"33","author":"Buchman","year":"2001","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.revmed.2007.06.002_bib9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/ki.1985.31","article-title":"Prednisolone pharmacokinetics in cushingoid and non-cushingoid kidney transplant patients","volume":"27","author":"Bergrem","year":"1985","journal-title":"Kidney Int."},{"key":"10.1016\/j.revmed.2007.06.002_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00007691-199204000-00017","article-title":"Use of a radioreceptor assay in the assessment of cushingoid features in patients with juvenile rheumatic diseases","volume":"14","author":"Lipnick","year":"1992","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.revmed.2007.06.002_bib11","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0016-5085(98)70254-9","article-title":"Budesonide versus prednisone in the treatment of active Crohn's disease. The Israeli Budesonide Study Group","volume":"115","author":"Bar-Meir","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.revmed.2007.06.002_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/gut.41.2.209","article-title":"Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group","volume":"41","author":"Campieri","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.revmed.2007.06.002_bib13","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.revmed.2007.06.002_bib14","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/rheumatology\/keg355","article-title":"Attitude of rheumatoid arthritis patients to treatment with oral corticosteroids","volume":"42","author":"Morrison","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.revmed.2007.06.002_bib15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2133.2007.07950.x","article-title":"Corticosteroid-induced clinical adverse events: frequency, risk factors and patient\u2019s feeling","volume":"157","author":"Fardet","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.revmed.2007.06.002_bib16","first-page":"863","article-title":"Endogenous and exogenous glucocorticoids in cushingoid patients","volume":"16","author":"Benet","year":"1982","journal-title":"Drug Intell. Clin. Pharm."},{"key":"10.1016\/j.revmed.2007.06.002_bib17","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1210\/jcem-53-5-1076","article-title":"Endogenous hydrocortisone, a possible factor contributing to the genesis of cushingoid habitus in patients on prednisone","volume":"53","author":"Frey","year":"1981","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.revmed.2007.06.002_bib18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1210\/jcem-51-3-561","article-title":"Prednisolone disposition in cushingoid and non-cushingoid kidney transplant patients","volume":"51","author":"Gambertoglio","year":"1980","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.revmed.2007.06.002_bib19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1210\/jcem-38-3-407","article-title":"Decreased clearance of prednisolone, a factor in the development of corticosteroid side effects","volume":"38","author":"Kozower","year":"1974","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.revmed.2007.06.002_bib20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.revmed.2006.12.013","article-title":"Corticoth\u00e9rapie syst\u00e9mique et alimentation: suivi des recommandations di\u00e9t\u00e9tiques et relation entre apports alimentaires et apparition d'une lipodystrophie","volume":"28","author":"Fardet","year":"2007","journal-title":"Rev. Med. Interne"},{"key":"10.1016\/j.revmed.2007.06.002_bib21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00126334-200309010-00008","article-title":"Gender differences in antiretroviral drug-related adipose tissue alterations. Women are at higher risk than men and develop particular lipodystrophy patterns","volume":"34","author":"Galli","year":"2003","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.revmed.2007.06.002_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00005792-200303000-00007","article-title":"Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature","volume":"82","author":"Misra","year":"2003","journal-title":"Medicine"},{"key":"10.1016\/j.revmed.2007.06.002_bib23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/135965350501000105","article-title":"Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study","volume":"10","author":"Young","year":"2005","journal-title":"Antivir. Ther."}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866307006108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866307006108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:21:28Z","timestamp":1759335688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866307006108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0248866307006108"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2007.06.002","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histoire naturelle de\u00a0la\u00a0lipodystrophie cervicofaciale cortico-induite: suivi prospectif d'une cohorte de\u00a037\u00a0patients","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2007.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}